Adam May on $ABVX's blowout data and subsequent stock crash (opens in new tab)
Abivax (ABVX) posted maybe the best ulcerative colitis data anyone's seen, then crashed 60% on a cancer signal Adam May argues is statistical noise.
Read the original article